Development of injectable, resorbable drug-releasing copolymer scaffolds for minimally invasive sustained ophthalmic therapeutics

Acta Biomaterialia

Volumn 8, Issue 7, 2012, Pages 2517-2528

  Fitzpatrick, Scott D ^a   Jafar Mazumder, M A ^a,b   Muirhead, Benjamin ^a   Sheardown, Heather ^a  

^a MCMASTER UNIVERSITY   (Canada)

^b KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS   (Saudi Arabia)

Author keywords

Drug delivery; N isopropylacrylamide; Ophthalmic materials; Resorbable; Retina

Indexed keywords

AMIDES; BYPRODUCTS; CARBOXYLIC ACIDS; CONTROLLED DRUG DELIVERY; MAGNETIC LEVITATION VEHICLES; SCAFFOLDS (BIOLOGY); TARGETED DRUG DELIVERY;

BUTYROLACTONES; COPOLYMER SCAFFOLDS; INJECTABLES; MINIMALLY INVASIVE; N-ISOPROPYLACRYLAMIDES; OPHTHALMIC MATERIAL; POSTERIOR SEGMENT; RESORBABLE; RETINA; RETINAL DEGENERATIVE DISEASE;

ACRYLIC MONOMERS;

ACRYLIC ACID COPOLYMER; AGENTS ACTING ON THE EYE; AMINE; BUTYROLACTONE; COPOLYMER; DEXAMETHASONE; N HYDROXYSUCCINIMIDE; PHOSPHATE BUFFERED SALINE; POLY(N ISOPROPYLACRYLAMIDE);

ARTICLE; CONJUGATION; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG RELEASE; HUMAN; HUMAN TISSUE; HYDROLYSIS; MINIMALLY INVASIVE PROCEDURE; PHASE TRANSITION; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; RETINA DEGENERATION; RING OPENING; WATER CONTENT;

EID: 84861588957     PISSN: 17427061     EISSN: 18787568     Source Type: Journal    
DOI: 10.1016/j.actbio.2012.03.018     Document Type: Article

References (33)

1. S.G. Schwartz, and H.W. Flynn Jr Pharmacotherapies for diabetic retinopathy: present and future ExpDiabetes Res 2007 2007 52487-1-8 10.1155/2007/52487
2. E.M. Del Amo, and A. Urtti Current and future ophthalmic drug delivery systems. A shift to the posterior segment Drug Discov Today 13 2008 135 143
3. A. Urtti Challenges and obstacles of ocular pharmacokinetics and drug delivery Adv Drug Deliv Rev 58 2006 1131 1135
4. R. Gaudana, J. Jwala, S.H. Boddu, and A.K. Mitra Recent perspectives in ocular drug delivery Pharm Res 26 2009 1197 1216
5. Y.E. Choonara, V. Pillay, M.P. Danckwerts, T.R. Carmichael, and L.C. du Toit A review of implantable intravitreal drug delivery technologies for the treatment of posterior segment eye diseases JPharmSci 99 2009 2219 2239
6. J.M. Morais, F. Papadimitrakopoulos, and D.J. Burgess Biomaterials/tissue interactions: possible solutions to overcome foreign body response AAPS J 12 2010 188 196
7. J.J. Kang Derwent, and W.F. Mieler Thermoresponsive hydrogels as a new ocular drug delivery platform to the posterior segment of the eye Trans Am Ophthalmol Soc 106 2008 206 213
8. M.S. Jardeleza, and J.W. Miller Review of anti-VEGF therapy in proliferative diabetic retinopathy Semin Ophthalmol 24 2009 87 92
9. S.D. Fitzpatrick, M.A.J. Mazumder, F. Lasowski, L.E. Fitzpatrick, and H. Sheardown PNIPAAm-grafted-collagen as an injectable, in situ gelling, bioactive cell delivery scaffold Biomacromolecules 11 2010 2261 2267
10. D. Neradovic, W.L.J. Hinrichs, J.J. Kettenes-van den Bosch, and W.E. Hennink Poly(N-isopropylacrylamide) with hydrolyzable lactic acid ester side groups: a new type of thermosensitive polymer Macromol Rapid Commun 20 1999 577 581
11. D. Neradovic, M.J. van Steenbergen, L. Vansteelant, Y.J. Meijer, C.F. van Nostrum, and W.E. Hennink Degradation mechanism and kinetics of thermosensitive polyacrylamides containing lactic acid side chains Macromolecules 36 2003 7491 7498
12. Z. Ma, D.M. Nelson, Y. Hong, and W.R. Wagner Thermally responsive injectable hydrogel incorporating methacrylate-polylactide for hydrolytic lability Biomacromolecules 11 2010 1873 1881
13. T. Yoshida, T. Aoyagi, E. Kokufuta, and T. Okano Newly designed hydrogel with both sensitive thermoresponse and biodegradability J Polym Sci Part A-Polym Chem 41 2003 779 787
14. Z.W. Cui, B.H. Lee, and B.L. Vernon New hydrolysis-dependent thermosensitive polymer for an injectable degradable system Biomacromolecules 8 2007 1280 1286
15. Z. Cui, B.H. Lee, C. Pauken, and B.L. Vernon Manipulating degradation time in a N-isopropylacrylamide-based co-polymer with hydrolysis-dependent LCST J Biomater Sci Polym Ed 21 2010 913 926
16. Mathy V. Biological evaluation of medical devices: identification and quantification of degradation products from polymeric medical devices. Geneva, Switzerland: 3rd ed. New york: International Organization for Standardization; 1998.
17. P.A. Quiram, C.R. Gonzales, and S.D. Schwartz Severe steroid-induced glaucoma following intravitreal injection of triamcinolone acetonide Am J Ophthalmol 141 2006 580 582
18. J.T. Thompson Cataract formation and other complications of intravitreal triamcinolone for macular edema Am J Ophthalmol 141 2006 629 637
19. A. Ruggiero, C.H. Villa, E. Bander, D.A. Rey, M. Bergkvist, and C.A. Batt Paradoxical glomerular filtration of carbon nanotubes Proc Natl Acad Sci USA 107 2010 12369 12374
20. C.A. Shah Diabetic retinopathy: a comprehensive review Indian J Med Sci 62 2008 500 519
21. S.S. Lee, and M.R. Robinson Novel drug delivery systems for retinal diseases. A review Ophthalmic Res 41 2009 124 135
22. B.D. Kuppermann Toxicity studies on triamcinolone acetonide and dexamethasone Retina Today 2010 4 13
23. A. Sharma, A. Pirouzmanesh, J. Patil, M.F. Estrago-Franco, L.C. Zacharias, and A. Pirouzmanesh Evaluation of the toxicity of triamcinolone acetonide and dexamethasone sodium phosphate on human lens epithelial cells (HLE B-3) J Ocul Pharmacol Ther 27 2011 265 271
24. A.J. Patil, A. Mansoor, A. Sharma, and B.D. Kuppermann Effects of dexamethasone on human trabecular meshwork cells in vitro 2009 Association for Research in Vision and Ophthalmology annual meeting Fort Lauderdale, FL
25. R. Narayanan, J.K. Mungcal, M.C. Kenney, G.M. Seigel, and B.D. Kuppermann Toxicity of triamcinolone acetonide on retinal neurosensory and pigment epithelial cells Invest Ophthalmol Vis Sci 47 2006 722 728
26. L.C. Zacharias, S. Luthra, J. Dong, and B.D. Kuppermann Effect of dexamethasone on mitochondrial func- tion and cell viability in human retinal pigment epithelial and rat neurosensory retinal cells in vitro 2007 Association for Research in Vision and Ophthalmology Annual Meeting Fort Lauderdale, FL
27. S.G. Schwartz, H.W. Flynn, and I.U. Scott Pharmacotherapy for diabetic retinopathy Expert Opin Pharmacother 10 2009 1123 1131
28. P.M. Beer, S.J. Bakri, R.J. Singh, W. Liu, G.B. Peters Iii, and M. Miller Intraocular concentration and pharmacokinetics of triamcinolone acetonide after a single intravitreal injection Ophthalmology 110 2003 681 686
29. L.S. Morse, S. Modjtahedi, and Z. Smit-McBride Use of intravitreal steroids in the clinic Retina Today 2010 6 10
30. J.A. Haller, B.D. Kuppermann, M.S. Blumenkranz, G.A. Williams, D.V. Weinberg, and C. Chou Randomized controlled trial of an intravitreous dexamethasone drug delivery system in patients with diabetic macular edema Arch Ophthalmol 128 2010 289 296
31. P.A. Campochiaro, G. Hafiz, S.M. Shah, S. Bloom, D.M. Brown, and M. Busquets Sustained ocular delivery of fluocinolone acetonide by an intravitreal insert Ophthalmology 117 2010 1393 1399
32. B.G. Ballios, M.J. Cooke, D. van der Kooy, and M.S. Shoichet A hydrogel-based stem cell delivery system to treat retinal degenerative diseases Biomaterials 31 2009 2555 2564
33. H. Sorg, C. Krueger, and B. Vollmar Intravital insights in skin wound healing using the mouse dorsal skin fold chamber J Anat 211 2007 810 818